| 12304939 |
EGFR and C-met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2025-05-20 |
| 12247077 |
Bispecific EGFR/c-Met antibodies |
Mark Chiu, Joost J. NEIJSSEN, Paul Parren, Janine Schuurman |
2025-03-11 |
| 12215160 |
Treatment of patients having c-met exon 14 skipping mutations |
Roland Knoblauch, Sylvie Laquerre |
2025-02-04 |
| 12215161 |
Combination therapies and patient stratification with bispecific anti-EGFR/c-Met antibodies |
Smruthi Vijayaraghavan |
2025-02-04 |
| 11879013 |
Combination therapies with bispecific anti-EGFR/c-Met antibodies and third generation EGFR tyrosine kinase inhibitors |
Sylvie Laquerre, Matthew Lorenzi |
2024-01-23 |
| 11459391 |
Combination therapies and patient stratification with bispecific anti-EGFR/c-Met antibodies |
Smruthi Vijayaraghavan |
2022-10-04 |
| 10954284 |
EGFR and c-Met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2021-03-23 |
| 10662235 |
Cysteine engineered fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Alastair King +5 more |
2020-05-26 |
| 9725497 |
EGFR and C-Met fibronectin type III domain binding molecules |
Mark Anderson, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2017-08-08 |
| 9695242 |
Bispecific EGFR/c-Met antibodies |
Mark Chiu, Joost J. NEIJSSEN, Paul Parren, Janine Schuurman |
2017-07-04 |
| 9695228 |
EGFR and c-Met fibronectin type III domain binding molecules |
Anderson Mark, Ricardo Attar, Michael Diem, Linus Hyun, Steven Jacobs +4 more |
2017-07-04 |
| 9593164 |
Bispecific EGFR/c-Met antibodies |
Mark Chiu, Joost J. NEIJSSEN, Paul Parren, Janine Schuurman |
2017-03-14 |
| 9580508 |
Bispecific EGFR/c-Met antibodies |
Mark Chiu, Joost J. NEIJSSEN, Paul Parren, Janine Schuurman |
2017-02-28 |
